# Carolina Aldworth

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/carolina-aldworth/

## Facts

| Field | Value |
| --- | --- |
| Citations | 48 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 3 |
| i10-index | 1 |
| Last Known Institution | Novartis (Switzerland) |
| OpenAlex ID | https://openalex.org/A5065030770 |
| Works | 33 |

## Researcher papers

- [Long-term outcomes of elderly kidney transplant recipients](https://scholariq.org/papers/long-term-outcomes-of-elderly-kidney-transplant-recipients-2/)
- [Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both](https://scholariq.org/papers/risk-of-hyperkalemia-with-empagliflozin-finerenone-or-both/)
- [Clinical and Humanistic Burden of IgA Nephropathy in Adult Patients](https://scholariq.org/papers/clinical-and-humanistic-burden-of-iga-nephropathy-in-adult-patients/)
- [Long-term outcomes of elderly kidney transplant recipients](https://scholariq.org/papers/long-term-outcomes-of-elderly-kidney-transplant-recipients/)
- [WCN24-479 CHARACTERISTICS OF PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT](https://scholariq.org/papers/wcn24-479-characteristics-of-patients-with-complement-3-glomerulopathy-c3g-in-a/)
- [Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone](https://scholariq.org/papers/acute-egfr-changes-and-their-mediation-of-albuminuria-reduction-with/)
- [POS-226 CORTICOSTEROID USE, INFECTION, AND ADVERSE EVENTS AMONG IMMUNOGLOBULIN A NEPHROPATHY (IgAN) PATIENTS IN A US REAL-WORLD SETTING](https://scholariq.org/papers/pos-226-corticosteroid-use-infection-and-adverse-events-among-immunoglobulin-a/)
- [Sexual dimorphism and age effects in CKD and type 2 diabetes in the CONFIDENCE trial](https://scholariq.org/papers/sexual-dimorphism-and-age-effects-in-ckd-and-type-2-diabetes-in-the-confidence/)
- [MO233: Real-World Signs and Symptoms at Diagnosis in Patients With IGA Nephropathy](https://scholariq.org/papers/mo233-real-world-signs-and-symptoms-at-diagnosis-in-patients-with-iga/)
- [#5514 IGA NEPHROPATHY: A REAL-WORLD COMPARISON BETWEEN DISEASE SEVERITY, SYMPTOM BURDEN, AND TREATMENT SATISFACTION REPORTED BY PATIENTS AND NEPHROLOGISTS](https://scholariq.org/papers/5514-iga-nephropathy-a-real-world-comparison-between-disease-severity-symptom/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [Novartis (Switzerland)](https://scholariq.org/institutions/novartis-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.